Illumina eyes its next move after jury hands down $334 million patent infringement verdict

Delaware federal jury found that Illumina infringed on two patents of Complete Genomics, a U.S. subsidiary of Chinese firm BGI. The San Diego gene sequencing market leader says it will appeal

Click here to view original post